More AVLT- participants than AVLT+ participants had an APOE ε4 allele and twice as many AVLT- participants as AVLT+ participants had baseline levels of CSF beta amyloid and tau consistent with AD (Shaw et al. 2009). This evidence concerns the gene MAPT and Alzheimer disease.